Digestive Diseases and Sciences

, Volume 55, Issue 11, pp 3059–3062 | Cite as

Hepatic Arteriovenous Malformations from Hereditary Hemorrhagic Telangiectasia: Treatment with Liver Transplantation

  • Maximilian Lee
  • Daniel Y. Sze
  • C. Andrew Bonham
  • Tami J. Daugherty
Stanford Multidisciplinary Seminars

Keywords

International Normalize Ratio Arteriovenous Malformation Hereditary Hemorrhagic Telangiectasia Hepatic Artery Embolization Autosomal Dominant Genetic Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Faughnan ME, Palda VA, Garcia-Tsao G, et al. International guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. J Med Genet. 2009 [Epub; PMID 19553198].Google Scholar
  2. 2.
    Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia. Am J Med Genet. 2000;91:66–67.CrossRefPubMedGoogle Scholar
  3. 3.
    Johnson DW, Berg JN, Baldwin MA, et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet. 1996;13:189–195.CrossRefPubMedGoogle Scholar
  4. 4.
    Garcia-Tsao G, Korzenik JR, Young L, et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med. 2000;343:931–936.CrossRefPubMedGoogle Scholar
  5. 5.
    Chavan A, Caselitz M, Karl-Friedrich G, et al. Hepatic artery embolization for treatment of patients with hereditary hemorrhagic telangiectasia and symptomatic hepatic vascular malformations. Eur Radiol. 2004;14:2079–2085.CrossRefPubMedGoogle Scholar
  6. 6.
    Koscielny A, Willinek WA, Hirner A, et al. Treatment of high output cardiac failure by flow-adapted hepatic artery banding (FHAB) in patients with hereditary hemorrhagic telangiectasia. J Gastrointest Surg. 2008;12:872–876.CrossRefPubMedGoogle Scholar
  7. 7.
    Boillot O, Bianco F, Viale JP, et al. Liver transplantation resolves the hyperdynamic circulation in hereditary hemorrhagic telangiectasia with hepatic involvement. Gastroenterology. 1999;116:187–192.CrossRefPubMedGoogle Scholar
  8. 8.
    Lerut J, Orlando G, Adam R, et al. Liver transplantation for hereditary hemorrhagic telangiectasia: report of the European liver transplant registry. Ann Surg. 2006;244:854–862.CrossRefPubMedGoogle Scholar
  9. 9.
    Sabba C, Gallitelli M, Longo A, et al. Orthotopic liver transplantation and hereditary hemorrhagic telangiectasia: do hepatic vascular malformations relapse? A long term follow up study on two patients. J Hepatol. 2004;41:687–689.CrossRefPubMedGoogle Scholar
  10. 10.
    Mitchell A, Adams LA, MacQuillan G, et al. Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia. Liver Transpl. 2008;14:210–213.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Maximilian Lee
    • 1
  • Daniel Y. Sze
    • 2
  • C. Andrew Bonham
    • 3
  • Tami J. Daugherty
    • 1
  1. 1.Division of Gastroenterology and Hepatology, Department of MedicineStanford University Medical CenterStanfordUSA
  2. 2.Division of Interventional Radiology, Department of RadiologyStanford University Medical CenterStanfordUSA
  3. 3.Multi-Organ Transplantation, Department of SurgeryStanford University Medical CenterStanfordUSA

Personalised recommendations